Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-05-07 @ 9:06 PM
Study NCT ID:
NCT02032004
Status:
COMPLETED
Last Update Posted:
2022-01-10
First Post:
2014-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure.
Sponsor:
Mesoblast, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Heart Failure | View |